What Factors Do You Use to Determine If an MF Patient Is, or Is Not, Benefitting from Long-Term Ruxolitinib Treatment?
Dr. Ruben Mesa, Mayo Clinic, answers the following question: What factors do you use to determine if an MF patient is, or is not, benefitting from long-term ruxolitinib treatment?
Recent Video
Most Popular
Specialties :                    Search :


MPNUniversity.tv is a member of the Oncology.TV family of oncology medical education websites. MPNUniversity.tv offers specialists, primary care physicians, and other healthcare professionals the timeliest comprehensive and relevant clinical information to improve patient care. We provide medical education (both free CE and non CE, including interactive case based presentations), news and information about Myeloproliferative Neoplasms (MPNs).